Digital program for the prevention and monitoring of metabolic diseases in at-risk adults

{
"level_sex_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D005260"
},
"value": "Female"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008297"
},
"value": "Male"
}
],
"level_age_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000328"
},
"value": "Adult (25 to 44 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008875"
},
"value": "Middle Aged (45 to 64 years)"
}
],
"level_type_clusion_I": "General population",
"level_type_clusion_other": "",
"clusion_I": "Aged between 25 and 64 Male or female BMI ≥ 25 kg\/m² (overweight or obese) High or impaired fasting blood glucose (≥ 1.05 g\/L) without a diagnosis of diabetes Residence in the geographical area covered by the study\r\n\r\nOwnership of a smartphone compatible with the application used Ability to understand the objectives of the study and to use a digital device Signed informed consent",
"clusion_E": "Diagnosed type 1 or type 2 diabetes Severe chronic condition that is not stable (cardiac, renal, hepatic, oncological)\r\n\r\nPregnancy or breastfeeding Medication that could significantly affect metabolism (e.g., prolonged corticosteroid therapy) Concurrent participation in another interventional study Inability to use digital tools or follow up on the study Refusal or withdrawal of consent"
}